IMPROVING RISK STRATIFICATION OF PATIENTS WITH NON-METASTATIC MEDULLOBLASTOMA: BIOMARKER ANALYSIS IN THE SIOP-EUROPE PNET4 CLINICAL TRIAL

被引：0
|
作者：
Pietsch, T. [1 ]
Gustafsson, G. [2 ]
Ellison, D. [3 ]
Figarella-Branger, D. [4 ]
Doz, F. [5 ]
Rutkowski, S. [6 ]
Lannering, B. [7 ]
Clifford, S. [8 ]
机构：
[1] Univ Bonn, Dept Neuropathol, Bonn, Germany
[2] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
[3] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38101 USA
[4] Univ Marseille, Fac Med Timone, Dept Pathol, Marseille, France
[5] Inst Curie, Dept Pediat Oncol, Paris, France
[6] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[7] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden
[8] Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：14 / 14
页数：1
相关论文
共 20 条
  • [1] BIOMARKER-DRIVEN STRATIFICATION OF DISEASE-RISK IN NON-METASTATIC MEDULLOBLASTOMA: THE SIOP-EUROPE PNET4 CLINICAL TRIAL
    Clifford, Steven
    Gustafsson, Goran
    Ellison, David
    Figarella-Branger, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Pietsch, Torsten
    NEURO-ONCOLOGY, 2012, 14 : 85 - 85
  • [2] BIOMARKER-DRIVEN STRATIFICATION OF DISEASE-RISK IN NON-METASTATIC MEDULLOBLASTOMA: THE SIOP-EUROPE PNET4 CLINICAL TRIAL
    Clifford, Steven
    Gustafsson, Goran
    Ellison, David
    Figarella-Branger, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Pietsch, Torsten
    NEURO-ONCOLOGY, 2013, 15 : 11 - 11
  • [3] STRATIFICATION OF CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA BY HISTOLOGICAL AND BIOLOGICAL PARAMETERS IN SIOP-EUROPE PNET CLINICAL TRIALS
    Clifford, S. C.
    Rutkowski, S.
    Gustafsson, G.
    Figarella-Branger, D.
    Kortmann, R. D.
    Doz, F.
    Ellison, D. W.
    Pietschs, T.
    NEURO-ONCOLOGY, 2010, 12 (06) : II6 - II6
  • [4] STRATIFICATION OF CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA BY HISTOLOGICAL AND BIOLOGICAL PARAMETERS IN SIOP-EUROPE PNET CLINICAL TRIALS
    Clifford, Steven
    Rutkowski, Stefan
    Gustafsson, Goran
    Figarella-Branger, Dominique
    Kortmann, Rolf
    Doz, Francois
    Lannering, Birgitta
    Ellison, David
    Pietsch, Torsten
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 799 - 799
  • [5] Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial
    Clifford, Steven C.
    Lannering, Birgitta
    Schwalbe, Ed C.
    Hicks, Debbie
    O'Toole, Kieran
    Nicholson, Sarah Leigh
    Goschzik, Tobias
    zur Muehlen, Anja
    Figarella-Branger, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Gustafsson, Goran
    Pietsch, Torsten
    ONCOTARGET, 2015, 6 (36) : 38827 - 38839
  • [6] Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial
    Bailey, Simon
    Andre, Nicolas
    Gandola, Lorenza
    Massimino, Maura
    Wheatley, Keith
    Gates, Simon
    Homer, Victoria
    Rutkowski, Stefan
    Clifford, Steven C.
    CANCERS, 2022, 14 (02)
  • [7] Validation of histological and biological parameters for clinical stratification of pediatric patients with medulloblastomas (SIOP-PNET 4 clinical trial)
    Pietsch, T.
    Rutkowski, S.
    Gustafsson, G.
    Figarella-Branger, D.
    Kortmann, R.
    Doz, F.
    Lannering, B.
    Ellison, D.
    Clifford, S.
    BRAIN PATHOLOGY, 2010, 20 : 73 - 73
  • [8] Pretreatment Central Quality Control for Craniospinal Irradiation and Tumorbed Boost in Non-Metastatic Medulloblastoma Treated in the SIOP PNET5 MB Trial in Germany and Switzerland
    Dietzsch, S.
    Braesigk, A.
    Seidel, C.
    Remmele, J.
    Kitzing, R.
    Schlender, T.
    Mynarek, M.
    Geismar, D.
    Jablonska, K.
    Schwarz, R.
    Pazos, M.
    Walser, M.
    Frick, S.
    Gurtner, K.
    Matuschek, C.
    Harrabi, S.
    Glueck, A.
    Lewitzki, V.
    Dieckmann, K.
    Benesch, M.
    Gerber, N.
    Rutkowski, S.
    Timmermann, B.
    Kortmann, R. -D.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S189 - S190
  • [9] Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
    Dietzsch, Stefan
    Braesigk, Annett
    Seidel, Clemens
    Remmele, Julia
    Kitzing, Ralf
    Schlender, Tina
    Mynarek, Martin
    Geismar, Dirk
    Jablonska, Karolina
    Schwarz, Rudolf
    Pazos, Montserrat
    Walser, Marc
    Frick, Silke
    Gurtner, Kristin
    Matuschek, Christiane
    Ben Harrabi, Semi
    Gluek, Albrecht
    Lewitzki, Victor
    Dieckmann, Karin
    Benesch, Martin
    Gerber, Nicolas U.
    Rutkowski, Stefan
    Timmermann, Beate
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (08) : 674 - 682
  • [10] Whole chromosomal aberration signatures predict survival in standard-risk non-WNT/non-SHH medulloblastoma: Molecular analysis of the HIT-SIOP-PNET4 clinical trial
    Pietsch, Torsten
    Goschzik, Tobias
    Schwalbe, Edward C.
    Hicks, Debbie
    Williamson, Daniel
    Figarella, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Clifford, Steven C.
    BRAIN PATHOLOGY, 2019, 29 : 186 - 186
12